Literature DB >> 20523052

Pleural granuloma mimicking malignancy 42 years after slurry talc injection for primary spontaneous pneumothorax.

S Tenconi1, L Luzzi, P Paladini, L Voltolini, M S Gallazzi, F Granato, G Gotti.   

Abstract

BACKGROUND: Talc poudrage is considered a safe pleurodesis technique to improve the results of video-assisted thoracoscopic surgery in cases of primary spontaneous pneumothorax (PSP).
METHODS: We report the case of a patient with left pleural pseudo-nodular plaque and a high metabolic rate upon PET scan suspected for malignancy, occurring 42 years after slurry talc injection for conservative treatment of PSP. The patient presented with coughing, chest pain and weight loss. Thoracotomy was required to obtain a diagnosis and perform a complete pleurectomy.
RESULTS: Histology was conclusive for pleural talc granuloma.
CONCLUSIONS: Indications and possible complications of talc use in young patients with PSP, and the management of possible consequent pleural lesions suspected for malignancy, need to be investigated. (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523052     DOI: 10.1159/000313503

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  3 in total

1.  Talc Pleurodesis With Intense 18F-FDG Activity But No 68Ga-DOTA-TATE Activity on PET/CT.

Authors:  Georgios Z Papadakis; Corina Millo; Ulas Bagci; Nicholas J Patronas; Constantine A Stratakis
Journal:  Clin Nucl Med       Date:  2015-10       Impact factor: 7.794

Review 2.  When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?

Authors:  Gang Cheng; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-30       Impact factor: 9.236

3.  Observational analysis on inflammatory reaction to talc pleurodesis: Small and large animal model series review.

Authors:  Jacopo Vannucci; Guido Bellezza; Alberto Matricardi; Giulia Moretti; Antonello Bufalari; Lucio Cagini; Francesco Puma; Niccolò Daddi
Journal:  Exp Ther Med       Date:  2017-11-07       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.